Skip to main content
SpringerLink
Log in

Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

A boy with combined immunodeficiency having low natural killer (NK)-cell activity received thymopoietin pentapeptide (TP-5) treatment, transplanted with T cell-depleted HLA-haploidentical bone marrow (BMT) cells from his father and with thymus tissue from an infant at different times during the first year of life. He showed a marked increase in large granular lymphocytes (LGL) both during the treatment with TP-5 and after BMT. The LGL generated following TP-5 injection had a T3+ Leu 11− surface phenotype and low NK activity. In contrast, the LGL appearing after BMT showed T3−, Leu7+, and/or Leu11+ surface phenotypes, had high NK- and K-cell activities, and were lymphokine-activated killer (LAK)-cell precursors. These killer activities were assigned to the Leu7− Leu11+ subset and proved to be of recipient origin. LGL proliferation following BMT was accompanied by neutropenia, which was improved in association with a reduction in the number of LGL and the appearance of T cells of BMT donor origin following thymus transplantation. This suggested the inhibition of granulopoiesis by the LGL and anin vitro study revealed that the Leu7+ Leu11− subset of LGL suppressed the growth of granulocyte/macrophage colony-forming units. These results indicated that phenotypically different LGL could be generated by different treatments and that the LGL showing NK activity were distinct from those regulating granulopoiesis. It was also suggested that the generation of LGL was controlled by T cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Saksela E, Timonen T, Ranki A, Häyry P: Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev 44:71–123, 1979

    Google Scholar 

  2. Timonen T, Ortaldo JR, Herberman RB: Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569–582, 1981

    Google Scholar 

  3. Trinchieri G, Perussia B: Human natural killer cells: Biologic and pathologic aspects. Lab Invest 50:489–513, 1984

    Google Scholar 

  4. Manara GC, De Panfilis G, Ferrari C, Bonati A, Rocchi G, Scandroglio R: Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype. Histochemistry 82:525–527, 1985

    Google Scholar 

  5. Manara GC, De Panfilis G, Ferrari C: Ultrastructural characterization of human large granular lymphocyte subsets defined by the expression of HNK-1(Leu-7), Leu-11, or both HNK-1 and Leu-11 antigens. J Histochem Cytochem 33:1129–1133, 1985

    Google Scholar 

  6. Ortaldo JR, Herberman RB: Heterogeneity of natural killer cells. Annu Rev Immunol 2:359–394, 1984

    Google Scholar 

  7. Loughran TP, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche C, Lum LG, Slichter SJ: Leukemia of large granular lymphocytes: Association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia and hemolytic anemia. Ann Intern Med 102:169–175, 1985

    Google Scholar 

  8. Chan WC, Link S, Mawle A, Check I, Brynes RK, Winton EF: Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes. Blood 68:1142–1153, 1986

    Google Scholar 

  9. Loughran TP, Starkebaum G: Clinical features in large granular lymphocytic leukemia. Blood 69:1786, 1987

    Google Scholar 

  10. Chan WC, Link, S, Waldmann TA, Mawle A, Check IJ, Winton EF: Type B large granular lymphocyte proliferation: A clinical, immunological and T-cell receptor gene rearrangement study. Lab Invest 56:12A, 1987

    Google Scholar 

  11. Allavena P, Ortaldo JR: Characteristics of human NK clones: Target specificity and phenotype. J Immunol 132:2363–2369, 1984

    Google Scholar 

  12. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841, 1982

    Google Scholar 

  13. Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA: Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymusderived lymphocytes, and natural killer cells. J Exp Med 157:884–897, 1983

    Google Scholar 

  14. Grimm EA, Robb RJ, Roth JA, Neckers LA, Lachman LB, Wilson DJ, Rosenberg SA: Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokineactivated killer cells. J Exp Med 158:1356–1361, 1983

    Google Scholar 

  15. Ortaldo JR, Mason A, Overton R: Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med 164:1193–1205, 1986

    Google Scholar 

  16. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889–897, 1987

    Google Scholar 

  17. Koren HS, Amos DB, Buckley RH: Natural killing in immunodeficient patients. J Immunol 120:796–799, 1978

    Google Scholar 

  18. Pross HF, Gupta S, Good RA, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Cell Immunol 43:160–175, 1979

    Google Scholar 

  19. Lipinski M, Virelizier JL, Tursz T, Griscelli C: Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production. Eur J Immunol 10:246–249, 1980

    Google Scholar 

  20. Lopez C, Kirkpatrick D, Fitzgerald PA, Ching CY, Pahwa RN, Good RA, Smithwick EM: Studies of cell lineage of the effector cells that spontaneously lyse HSV-1-infected fibroblasts(NK(HSV-1)). J Immunol 129:824–828, 1982

    Google Scholar 

  21. Peter HH, Friedrich W, Dopfer R, Müller W, Kortmann C, Pichler WJ, Heinz F, Rieger CHL: NK cell function in severe combined immunodeficiency (SCID): Evidence of a common T and NK cell defect in some but not all SCID patients. J Immunol 131:2332–2339, 1983

    Google Scholar 

  22. Messina C, Kirkpatrick D, Fitzgerald PA, O'Reilly RJ, Siegal FP, Cunningham-Rundles C, Blaese M, Oleske J, Pahwa S, Lopez C: Natural killer cell function and interferon generation in patients with primary immunodeficiencies. Clin Immunol Immunopathol 39:394–404, 1986

    Google Scholar 

  23. Rosen FS, Wedgwood RJ, Aiuti F, Hitzig WH, Cooper MD, Matsumoto S, Good RA, Seligmann M, Hanson LA, Soothill JF, Waldmann TA: Primary immunodeficiency diseases: report prepared for the WHO by a scientific group on immunodeficiency. Clin Immunol Immunopathol 28:450–475, 1983

    Google Scholar 

  24. Goldstein G, Scheid MP, Boyse EA, Schlesinger DH, Van Wauwe J: A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204:1309–1310, 1979

    Google Scholar 

  25. Ault KA, Antin JH, Ginsburg D, Orkin SH, Rappeport JM, Keohan ML, Martin P, Smith BR: Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 161:1483–1502, 1985

    Google Scholar 

  26. Lum LG: The kinetics of immune reconstitution after human marrow transplantation. Blood 69:369–380, 1987

    Google Scholar 

  27. Hercend T, Takvorian T, Nowill A, Tantravahi R, Moingeon P, Anderson KC, Murray C, Bohuon C, Ythier A, Ritz J: Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 67:722–728, 1986

    Google Scholar 

  28. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136:2398–2407, 1986

    Google Scholar 

  29. Abo T, Miller CA, Balch CM: Characterization of human granular lymphocyte subpopulations expressing HNK-1(Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Eur J Immunol 14:616–623, 1984

    Google Scholar 

  30. Morris TCM, Vincent PC, Sutherland R, Hersey P: Inhibition of normal human granulopoiesis in vitro by non-B non-T lymphocytes. Br J Hematol 45:541–550, 1980

    Google Scholar 

  31. Hansson M, Beran M, Andersson B, Kiessling R: Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J Immunol 129:126–132, 1982

    Google Scholar 

  32. Degliantoni G, Perussia B, Mangoni L, Trinchieri G: Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med 161:1152–1168, 1985

    Google Scholar 

  33. Matera L, Santoli D, Garbarino G, Pegoraro L, Bellone G, Pagliardi G: Modulation of in vitro myelopoiesis by LGL: Different effects on early and late progenitor cells. J Immunol 136:1260–1265, 1986

    Google Scholar 

  34. Nagasawa T, Abe T, Nakagawa T: Pure red cell aplasia and hypogammaglobulinemia associated with Tr-cell chronic lymphocytic leukemia. Blood 57:1025–1031, 1981

    Google Scholar 

  35. Hocking WG, Singh R, Schroff R, Golde DW: Cell mediated inhibition of erythropoiesis and megaloblastic anemia in T-cell chronic lymphocytic leukemia. Cancer 51:631–636, 1983

    Google Scholar 

  36. Palutke M, Eisenberg L, Kaplan J, Hussain M, Kithier K, Tabaczka P, Mirchandani I, Tenenbaum D: Natural killer and suppressor T-cell chronic lymphocytic leukemia. Blood 62:627–634, 1983

    Google Scholar 

  37. Winton EF, Chan WC, Check I, Colenda KW, Bongiovanni KF, Waldmann TA: Spontaneous regression of a monoclonal proliferation of large granular lymphocytes associated with reversal of anemia and neutropenia. Blood 67:1427–1432, 1986

    Google Scholar 

  38. Loughran TP, Clark EA, Price TH, Hammond WP: Adultonset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 68:1082–1087, 1986

    Google Scholar 

  39. Koizumi S, Seki H, Tachinami T, Taniguchi M, Matsuda A, Taga K, Nakarai T, Kato E, Taniguchi N, Nakamura H: Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7-− surface phenotype: In vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 68:1065–1073, 1986

    Google Scholar 

  40. Pross HF, Pater J, Dwosh I, Giles A, Gallinger LA, Rubin P, Corbett WEN, Galbraith P, Baines MG: Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity. J Clin Immunol 2:126–134, 1982

    Google Scholar 

  41. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY: Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocytemacrophage (CFU-GM) progenitor cells. J Immunol 131:1300–1305, 1983

    Google Scholar 

  42. Raefsky EL, Platanias LC, Zoumbos NC, Young NS: Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 135:2507–2512, 1985

    Google Scholar 

  43. Lanier LL, Kipps TJ, Phillips JH: Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu11 antigen). J Exp Med 162:2089–2106, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, 113, Tokyo, Japan

    Shuji Takagi, Junichi Minakuchi, Hiroji Okawa & Junichi Yata

Authors
  1. Shuji Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Junichi Minakuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroji Okawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junichi Yata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takagi, S., Minakuchi, J., Okawa, H. et al. Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency. J Clin Immunol 9, 39–47 (1989). https://doi.org/10.1007/BF00917126

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917126

Key words

Search

Navigation